全文获取类型
收费全文 | 2820篇 |
免费 | 169篇 |
国内免费 | 13篇 |
专业分类
耳鼻咽喉 | 35篇 |
儿科学 | 95篇 |
妇产科学 | 51篇 |
基础医学 | 432篇 |
口腔科学 | 48篇 |
临床医学 | 235篇 |
内科学 | 488篇 |
皮肤病学 | 92篇 |
神经病学 | 257篇 |
特种医学 | 96篇 |
外科学 | 372篇 |
综合类 | 95篇 |
预防医学 | 165篇 |
眼科学 | 87篇 |
药学 | 257篇 |
中国医学 | 18篇 |
肿瘤学 | 179篇 |
出版年
2023年 | 19篇 |
2022年 | 31篇 |
2021年 | 81篇 |
2020年 | 31篇 |
2019年 | 66篇 |
2018年 | 82篇 |
2017年 | 47篇 |
2016年 | 71篇 |
2015年 | 70篇 |
2014年 | 82篇 |
2013年 | 114篇 |
2012年 | 177篇 |
2011年 | 199篇 |
2010年 | 125篇 |
2009年 | 71篇 |
2008年 | 120篇 |
2007年 | 127篇 |
2006年 | 124篇 |
2005年 | 100篇 |
2004年 | 97篇 |
2003年 | 78篇 |
2002年 | 77篇 |
2001年 | 62篇 |
2000年 | 85篇 |
1999年 | 69篇 |
1998年 | 23篇 |
1996年 | 14篇 |
1995年 | 19篇 |
1994年 | 19篇 |
1992年 | 40篇 |
1991年 | 38篇 |
1990年 | 44篇 |
1989年 | 45篇 |
1988年 | 32篇 |
1987年 | 40篇 |
1986年 | 37篇 |
1985年 | 37篇 |
1984年 | 31篇 |
1983年 | 27篇 |
1982年 | 18篇 |
1981年 | 18篇 |
1980年 | 25篇 |
1979年 | 29篇 |
1978年 | 15篇 |
1977年 | 20篇 |
1976年 | 12篇 |
1975年 | 12篇 |
1974年 | 10篇 |
1973年 | 14篇 |
1969年 | 11篇 |
排序方式: 共有3002条查询结果,搜索用时 15 毫秒
41.
Sripad V. Khairnar Ranjit Kumar Nath Balram Yadav Kakasaheb Bhosale Sulabh Chandraker 《Indian heart journal》2021,73(1):44-48
ObjectiveThe study aimed at to find out prevalence of abnormal upper limb arterial anatomy and its correlation with access failure during transradial coronary angiography.MethodThis was a prospective observational study of 1512 patients who had undergone transradial coronary angiography (CAG). Angiographic assessment of upper limb arterial tree was performed when the angiographic guidewire or the diagnostic catheter followed an abnormal path or got stuck in its course.ResultsAbout 5.29% patients (80/1512) were noted to have abnormal upper limb arterial anatomy. The most common abnormality detected were radio-ulnar loop in 22 (1.46%) patients, tortuous upper limb arteries 19 (1.25%) and abnormal high origin of radial artery 10 (0.66%) patients. Access failure was encountered in 4.4% (67/1512) of total patients and 64.17% (43/67) access failure was due to abnormal upper limb arterial anatomy.ConclusionAbnormal upper limb arterial anatomy was the most common cause of access failure in transradial coronary angiography in this study. 相似文献
42.
Effects of cyclosporine on the renin-angiotensin-aldosterone system and potassium excretion in renal transplant recipients 总被引:2,自引:0,他引:2
J P Bantle K A Nath D E Sutherland J S Najarian T F Ferris 《Archives of internal medicine》1985,145(3):505-508
To evaluate the mechanism of cyclosporine-induced hyperkalemia, the renin-angiotensin-aldosterone system and renal potassium clearance were compared in ten renal transplant recipients treated with cyclosporine and treated with azathioprine. After stimulation by a low-sodium diet and furosemide, cyclosporine-treated patients demonstrated lower plasma renin activity when supine (1.9 +/- 0.3 v 7.8 +/- 1.4 ng/mL/hr) and after standing (3.0 +/- 0.7 v 12.2 +/- 1.5 ng/mL/hr). Supine plasma aldosterone levels tended to be lower in cyclosporine-treated patients, (4.8 +/- v 10.5 +/- 2.6 ng/dL), although standing plasma aldosterone levels were not different (10.8 +/- 3.0 v 12.3 +/- 2.0 ng/dL). After administration of 0.75 mEq of potassium chloride per kilogram of body weight, cyclosporine-treated patients excreted 52% +/- 7.1% of the potassium load in six hours compared with excretion of 67% +/- 7.0% by the azathioprine-treated patients, although there was no difference in plasma aldosterone levels in response to the potassium load in the two groups. These data suggest that cyclosporine causes suppression of plasma renin activity and a tubular insensitivity to aldosterone, both of which may impair potassium excretion. 相似文献
43.
44.
45.
46.
47.
Suneet Kaur Gautam Srivastava Amar Nath Sharma Ravinder S Jolly 《British journal of pharmacology》2015,172(9):2286-2299
Background and Purpose
Recently, we have described the use of caerulomycin A (CaeA) as a potent novel immunosuppressive agent. Immunosuppressive drugs are crucial for long-term graft survival following organ transplantation and treatment of autoimmune diseases, inflammatory disorders, hypersensitivity to allergens, etc. The objective of this study was to identify cellular targets of CaeA and decipher its mechanism of action.Experimental Approach
Jurkat cells were treated with CaeA and cellular iron content, iron uptake/release, DNA content and deoxyribonucleoside triphosphate pool determined. Activation of MAPKs; expression level of transferrin receptor 1, ferritin and cell cycle control molecules; reactive oxygen species (ROS) and cell viability were measured using Western blotting, qRT-PCR or flow cytometry.Key Results
CaeA caused intracellular iron depletion by reducing its uptake and increasing its release by cells. CaeA caused cell cycle arrest by (i) inhibiting ribonucleotide reductase (RNR) enzyme, which catalyses the rate-limiting step in the synthesis of DNA; (ii) stimulating MAPKs signalling transduction pathways that play an important role in cell growth, proliferation and differentiation; and (iii) by targeting cell cycle control molecules such as cyclin D1, cyclin-dependent kinase 4 and p21CIP1/WAF1. The effect of CaeA on cell proliferation was reversible.Conclusions and Implications
CaeA exerts its immunosuppressive effect by targeting iron. The effect is reversible, which makes CaeA an attractive candidate for development as a potent immunosuppressive drug, but also indicates that iron chelation can be used as a rationale approach to selectively suppress the immune system, because compared with normal cells, rapidly proliferating cells require a higher utilization of iron. 相似文献48.
Dhingra Gaurav Maji Manideepa Mandal Saikat Vaniyath Sudeep Negi Gita Nath Uttam Kumar 《Journal of thrombosis and thrombolysis》2021,52(2):504-507
Journal of Thrombosis and Thrombolysis - Thrombotic thrombocytopenic purpura (TTP) which can cause significant mortality is a thrombotic microangiopathy due to deficiency of VWF cleaving protease... 相似文献
49.
Kumar Umesh Kumar Abhai Singh Smita Arya Payal Singh Sandeep Kumar Chaurasia Rameshwar Nath Singh Anup Kumar Dinesh 《Metabolic brain disease》2021,36(5):957-968
Metabolic Brain Disease - Mild cognitive impairment (MCI) is transition phase between cognitive decline and dementia. The current study aims to investigate altered metabolic pattern in plasma of... 相似文献
50.
Jaya Prakash Nath Ambinathan Vikas S. Sridhar Yuliya Lytvyn Leif Erik Lovblom Hongyan Liu Petter Bjornstad Bruce A. Perkins Julie A. Lovshin David Z.I. Cherney 《Journal of diabetes and its complications》2021,35(5):107880
The renin angiotensin aldosterone system (RAAS) is associated with renal disease and inflammation in a diabetes setting, however, little is known about the implicated mechanisms in individuals with long standing diabetes. Accordingly, our aim was to perform an observational study to quantify urinary excretion of inflammatory biomarkers in participants with long standing type 1 diabetes (T1D) (with and without diabetic kidney disease [DKD]) and controls, at baseline and in response to RAAS activation. GFRINULIN, ERPFPAH, and 42 urine inflammatory biomarkers were measured in 74 participants with T1D for ≥50 years (21 with DKD and 44 without DKD [DKD resistors]) and 73 healthy controls. Additionally, inflammatory biomarkers were measured before and after an angiotensin II infusion (ANGII, 1 ng?kg?1?min?1). Significantly lower urinary excretion of cytokines (IL-18, IL-1RA, IL-8), chemokines (MCP1, RANTES) and growth factors (TGF-α, PDGFAA, PDGFBB, VEGF-A) was observed in participants with T1D at baseline compared to controls. Urinary IL-6 was higher in DKD than in DKD resistors in an exploratory analysis unadjusted for multiple comparisons. In T1D only, lower GFRINULIN correlated with greater excretion of proinflammatory biomarkers (IL-18, IP-10, & RANTES), growth factors (PDGF-AA & VEGFAA), and chemokines (eotaxin & MCP-1). ANGII increased 31 of 42 inflammatory biomarkers in T1D vs controls (p < 0.05), regardless of DKD resistor status. In conclusion, lower GFR and intra-renal RAAS activation were associated with increased inflammation even after longstanding T1D. The increased urinary IL-6 in patients with DKD requires further investigation to determine whether IL-6 is a candidate protective biomarker for prognostication or targeted therapy in DKD. 相似文献